40 citations
,
May 2010 in “Australasian Journal of Dermatology”
This study suggests that chronic telogen effluvium may be due to a reduction in the variance of anagen duration, resulting in recurrent hair shedding with minimal long-term hair volume loss.
September 2025 in “Journal of Cosmetic Dermatology”
In this study, the use of rb‐bFGF in hair transplantation significantly increased follicle survival, reduced hairloss, improved patient satisfaction, and decreased complications compared to controls, in patients with androgenetic alopecia over a 12-month period.
This study found that disease duration was the only independent risk factor for increased severity of female pattern hairloss, rather than elements, vitamins, or hormones.
A user is seeking experiences with adenosine for hairloss, asking about its effectiveness, usage duration, and combination with treatments like minoxidil, finasteride, or RU58841. Another user mentions difficulty sourcing adenosine and comments on the mixed quality of research.
Dutasteride and finasteride can significantly slow or halt hairloss, with some users experiencing regrowth, but results vary. Lifestyle factors and individual genetic predispositions also play a role in hairloss outcomes.
GT20029 is a new hairloss treatment in Phase 3 trials in China, using PROTAC technology to target androgen receptors, potentially with fewer side effects than finasteride and minoxidil. VDPHL01, a second-generation minoxidil, is also mentioned as potentially more effective.
A person improved hairloss from Norwood 3 to Norwood 2 using a topical formula with minoxidil, dutasteride, and tretinoin, plus oral minoxidil and red light therapy. There is skepticism about the treatment's effectiveness and concerns about misleading comparison photos.
Creatine may cause hairloss in some individuals, especially those on finasteride, despite no scientific link. Personal experiences suggest individual sensitivity to DHT could be a factor.